Marek Wozny graduated in Biology and Biomedical Application in 2022 at University of Parma.

From May 2022 to June 2023 – He has been exposed to cutting-edge international research as graduated student in the Division of Molecular Oncology of Gastrointestinal Tumors  at the DKFZ, Heidelberg,  working on reactive T-cells receptors in pancreatic cancer.

December 2022 to current – He entered in the PhD Programme in Molecular and Experimental Medicine at the Humanitas University studying how B lymphocytes contribute to tissue fibrosis in Inflammatory Bowel Disease. Additionally, Marek is involved in the identification of new circulating biomarkers in Ulcerative Colitis patients under the H2020 ImmUniverse project (IMI2).